Treatment of Pulmonary SUlcus, Pancoast and Chest Wall Non-small Cell Lung Cancer Employing Radiation, Immuno-oncology and Resection

Conditions: Lung Cancer Patients; Non-small Cell Lung Cancer (NSCLC) Interventions: Drug: Durvalumab; Radiation: Non-ablative oligofractionated radiation (NORT) Sponsors: Marc de Perrot; Ozmosis Research Inc. Not yet recruiting

https://clinicaltrials.gov/study/NCT06331455

Source: ClinicalTrials.gov - March 26, 2024 Category: Research Source Type: clinical trials

More News: Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Research